AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Solid Biosciences Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00JN4FXH7
5.92▼ 0.27 (-4.36%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
6.19
Day's Range
5.78 – 6.23
52-Week Range
3.79 – 11.45
Volume
770.0K
Avg Volume
1.5M
Share Statistics
Shares Outstanding
Employees
121
Exchange
XNAS
Listed
2018-01-25
Share count as of August 4, 2026

Solid Biosciences Inc. Common Stock (SLDB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Solid Biosciences Inc. Common Stock (SLDB)
What is Solid Biosciences Inc. Common Stock's Market Cap?
Solid Biosciences Inc. Common Stock's Market Cap is $634.8M, based on as-reported figures from SEC (XBRL) filings.
What is Solid Biosciences Inc. Common Stock's Enterprise Value?
Solid Biosciences Inc. Common Stock's Enterprise Value is $475.4M, based on as-reported figures from SEC (XBRL) filings.
What is Solid Biosciences Inc. Common Stock's EV / EBITDA?
Solid Biosciences Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Solid Biosciences Inc. Common Stock's Net Income (TTM)?
Solid Biosciences Inc. Common Stock's Net Income (TTM) is -$207.1M, based on as-reported figures from SEC (XBRL) filings.
What is Solid Biosciences Inc. Common Stock's EBITDA?
Solid Biosciences Inc. Common Stock's EBITDA is -$210.5M, based on as-reported figures from SEC (XBRL) filings.
What is Solid Biosciences Inc. Common Stock's Diluted EPS (TTM)?
Solid Biosciences Inc. Common Stock's Diluted EPS (TTM) is -1.93, based on as-reported figures from SEC (XBRL) filings.
What is Solid Biosciences Inc. Common Stock's Net Debt?
Solid Biosciences Inc. Common Stock's Net Debt is -$159.4M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SLDBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Collaboration revenue - related party————
YoY growth————
Operating expenses:
Research and development
General and administrative
Restructuring charges————
Total operating expenses
% of revenue————
Loss from operations
% of revenue————
Other income, net:
Interest income
Interest expense——
Change in fair value of derivative liabilities
Other income, net
Total other income, net
Net loss
% of revenue————
Net loss per share, basic
Net loss per share, diluted